![Anti-gp100 antibody [BUSA14]](https://cancertools.org/wp-content/uploads/6501ce87-678c-4f71-94ab-2a1ae4c39748.png)
![Anti-gp100 antibody [BUSA14] - Image 2](https://cancertools.org/wp-content/uploads/776a209f-a8f0-490d-8cfb-5f9be9cc1dd3.png)
![Anti-gp100 antibody [BUSA14] - Image 3](https://cancertools.org/wp-content/uploads/db23de78-0831-452c-bf4f-03facb34bd7d.png)
![Anti-gp100 antibody [BUSA14] - Image 4](https://cancertools.org/wp-content/uploads/5022e67d-3ccc-4937-80a5-5cd50443e39b.png)
Cat. #160883
Anti-gp100 antibody [BUSA14]
Cat. #: 160883
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: gp100(25-33) melanoma antigens
Class: Monoclonal
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Lea Eisenbach
Institute: Weizmann Institute Of Science
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-gp100 antibody [BUSA14]
- Research fields: Cancer;Immunology
- Clone: BUSA14
- Tool sub type: Primary antibody
- Class: Monoclonal
- Host: Mouse
- Description: BUSA14 offers a quantifiable, cheap and straightforward tool for studying peptide presentation by MHC-I molecules on the cell surface.
Target Details
- Target: gp100(25-33) melanoma antigens
Handling
- Unit size: 100 ug
- Shipping conditions: Shipping at 4° C
References
- Cafri et al. 2013. PLoS One. 8(2):e55583. PMID: 23383339.
